Suppr超能文献

网络荟萃分析比较微创心脏手术中血心停搏液、Del Nido 心停搏液和 Custodiol 心停搏液。

Network meta-analysis comparing blood cardioplegia, Del Nido cardioplegia and custodiol cardioplegia in minimally invasive cardiac surgery.

机构信息

Department of Cardiac Surgery, 156594Bristol Heart Institute, Bristol, UK.

Department of Perfusion Sciences, 156611St George's Hospital, London UK.

出版信息

Perfusion. 2023 Apr;38(3):464-472. doi: 10.1177/02676591221075522. Epub 2022 Feb 27.

Abstract

INTRODUCTION

Minimally invasive cardiac surgery has been evolving, with the intention of reducing surgical trauma, improve cosmesis and patient satisfaction. Single dose, crystalloid cardioplegia such as Del Nido cardioplegia and Custoidol solution have been increasingly used to reduce the interruption from repeating cardioplegia dosing to minimise the cardiopulmonary bypass and cross clamp time. However, the best cardioplegia for myocardial protection in adult minimally invasive cardiac surgery remains controversial. We aimed to conduct a meta-analysis to analyse the current evidence in the literature.

METHOD

A systematic review and meta-analysis was performed following the updated 2020 PRISMA guideline. Articles published in the five major electronic databases up 1st of April 2021 were identified and reviewed. The primary outcome was in-hospital or 30-day mortality. Traditional pairwise and Bayesian network meta-analyses were conducted.

RESULTS

Nine articles were included in this study. The use of Del Nido cardioplegia was associated with a lower volume of cardioplegia used (Del Nido vs Blood, 1105.62 mL+/-123.47 vs 2569.46 mL+/-1515.52, <0.001), cardiopulmonary bypass (Del Nido vs Custoidol vs Blood: 91.67+/-14.78 vs 138.05 +/- 21.30 vs 119.38+/-26.91 minutes, <0.001) and cross-clamp time (Del Nido vs Custoidol vs Blood: 74.99+/-18.55 vs 82.01 +/- 17.28 vs 93.66+/-8.88 minutes, < 0.001). No differences were observed in the incidence of in-hospital/30-day mortality rate, new onset of atrial fibrillation and stroke. Ranking analysis showed the Custoidol solution has the highest probability to be the first ranked cardioplegia.

CONCLUSION

No differences were found between blood and crystalloid cardioplegia in adult minimally invasive cardiac surgery in several clinical outcomes. The cardioplegia of choice in minimally invasive cardiac surgery remains the surgeons' decision and preference.

摘要

简介

微创心脏外科一直在发展,目的是减少手术创伤,改善美容效果和患者满意度。单次剂量的晶体心脏停搏液,如 Del Nido 心脏停搏液和 Custoidol 溶液,已被越来越多地用于减少重复心脏停搏液给药的中断,以尽量减少体外循环和交叉夹闭时间。然而,成人微创心脏手术中最佳的心肌保护心脏停搏液仍存在争议。我们旨在进行荟萃分析以分析文献中的现有证据。

方法

根据 2020 年更新的 PRISMA 指南进行系统评价和荟萃分析。确定并审查了截至 2021 年 4 月 1 日在五个主要电子数据库中发表的文章。主要结局是院内或 30 天死亡率。进行了传统的成对和贝叶斯网络荟萃分析。

结果

本研究纳入了 9 篇文章。使用 Del Nido 心脏停搏液与使用的心脏停搏液量较少相关(Del Nido 与血液,1105.62±123.47 与 2569.46±1515.52,<0.001)、体外循环(Del Nido 与 Custoidol 与血液:91.67±14.78 与 138.05 +/- 21.30 与 119.38±26.91 分钟,<0.001)和交叉夹闭时间(Del Nido 与 Custoidol 与血液:74.99±18.55 与 82.01 +/- 17.28 与 93.66±8.88 分钟,<0.001)。院内/30 天死亡率、新发心房颤动和中风的发生率无差异。排名分析表明,Custoidol 溶液最有可能成为排名第一的心脏停搏液。

结论

在成人微创心脏手术中,血液和晶体心脏停搏液在几个临床结局方面没有差异。微创心脏手术中心脏停搏液的选择仍然是外科医生的决定和偏好。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验